ElectromeElectrome home
Buy ActiPatch®
Electrome · Evidence

How Bioelectric Therapy May Work

Plain-English mechanism summaries grounded in preclinical and mechanism-of-action publications.

publication

Meta-analysis of Clinical Efficacy of Pulsed Radio Frequency Energy Treatment

Synthesis of clinical PRFE evidence across postoperative recovery, chronic pain, wound healing, and musculoskeletal indications.

View source
publication

Pulsed Radiofrequency Electromagnetic Field Therapy as an Adjunct Wound Healing Therapy

Narrative review of PRFE therapy as an adjunctive approach across chronic wound, postoperative healing, and cellular tissue-repair literature.

View source
publication

Pulsed Radiofrequency Energy Accelerates Impaired Wound Healing

Controlled preclinical model evaluating wound-closure and contraction dynamics under pulsed radiofrequency energy exposure.

View source
publication

Electromagnetic Field Exposure and Osteoprogenitor Differentiation

Laboratory investigation of whether controlled electromagnetic field exposure measurably affects osteoprogenitor cell differentiation markers.

View source
Educational summary only. Not medical advice. Individual results vary. Consult a qualified healthcare provider before making treatment decisions. ActiPatch® is FDA-cleared (K192234) for musculoskeletal pain; RecoveryRx® is FDA-cleared (K190251) for adjunctive treatment of postoperative pain. Study outcomes such as edema reduction are evidence findings, not additional cleared indications. Both devices are developed and manufactured by BioElectronics Corporation and marketed by Electrome under an exclusive license.